Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep neuromuscular block with sugammadex reversal in deltopectoral shoulder surgery
2018-002961-21Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of rocuronium and Sugammadex (2 arms), sponsored by UZ Leuven. Primary endpoint: Modified Leiden score. Started Sep 2018; status: completed.
02
Drugs
rocuroniumSugammadex
Beyond the preview
Go deeper on 2018-002961-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002961-21.